{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T21:20:26Z","timestamp":1774473626075,"version":"3.50.1"},"reference-count":114,"publisher":"IMR Press","issue":"5","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Integr. Neurosci."],"abstract":"<jats:p>Optical coherence tomography (OCT) is a non-invasive imaging technique in the field of ophthalmology that has been increasingly recognized for its capability to identify potential biomarkers in neurodegenerative processes. While the retinal nerve fiber layer (RNFL) has been vastly explored, this review focuses on the ganglion cell layer (GCL), highlighting its relevance and potential advantages in the diagnostic approach and monitoring of neurodegenerative conditions. In the present review we explore the role of GCL changes detected by OCT in Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), and multiple sclerosis (MS). We focus on these conditions due to their prevalence and substantial social impact among neurodegenerative diseases. We summarize key findings on the changes in the GCL and their correlations with disease progression and severity. Moreover, we highlight GCL measurements in the context of a multidisciplinary diagnostic approach, and their potential in adapting tailored therapeutic strategies in neurodegenerative disease management. Challenges such as methodological variability in OCT measurements, automatic instrumental output parameters, the limitations of GCL as a standalone diagnostic tool, and the impact of systemic and ocular factors are discussed. Finally, we propose that forthcoming advancements in OCT technology, integration with other biomarkers, and longitudinal studies will likely further enhance the understanding of GCL changes over time.<\/jats:p>","DOI":"10.31083\/jin26039","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T12:23:53Z","timestamp":1749039833000},"source":"Crossref","is-referenced-by-count":5,"title":["The Role of the Ganglion Cell Layer as an OCT Biomarker in Neurodegenerative Diseases"],"prefix":"10.31083","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0095-6585","authenticated-orcid":true,"given":"Francesco","family":"Ruggeri","sequence":"first","affiliation":[{"name":"Ophthalmology Unit, Neurosciences, Mental Health, and Sense Organs (NESMOS) Department, Faculty of Medicine and Psychology, University of Rome Sapienza, 00189 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4913-1259","authenticated-orcid":true,"given":"Daniele","family":"Fumi","sequence":"first","affiliation":[{"name":"Ophthalmology Unit, Neurosciences, Mental Health, and Sense Organs (NESMOS) Department, Faculty of Medicine and Psychology, University of Rome Sapienza, 00189 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Bassis","sequence":"first","affiliation":[{"name":"Ophthalmology Unit, Neurosciences, Mental Health, and Sense Organs (NESMOS) Department, Faculty of Medicine and Psychology, University of Rome Sapienza, 00189 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1089-2060","authenticated-orcid":true,"given":"Mariachiara Di","family":"Pippo","sequence":"first","affiliation":[{"name":"Ophthalmology Unit, Neurosciences, Mental Health, and Sense Organs (NESMOS) Department, Faculty of Medicine and Psychology, University of Rome Sapienza, 00189 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0920-8732","authenticated-orcid":true,"given":"Solmaz","family":"Abdolrahimzadeh","sequence":"first","affiliation":[{"name":"Ophthalmology Unit, Neurosciences, Mental Health, and Sense Organs (NESMOS) Department, Faculty of Medicine and Psychology, University of Rome Sapienza, 00189 Rome, Italy"},{"name":"Ophthalmology Unit, Department of Surgical Sciences, St. Andrea Hospital, 00189 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Jones-Odeh E, Hammond CJ. How strong is the relationship between glaucoma, the retinal nerve fibre layer, and neurodegenerative diseases such as Alzheimer\u2019s disease and multiple sclerosis? Eye. 2015; 29: 1270\u20131284.","DOI":"10.1038\/eye.2015.158."},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Trebbastoni A, D\u2019Antonio F, Bruscolini A, Marcelli M, Cecere M, Campanelli A, et al. Retinal nerve fibre layer thickness changes in Alzheimer\u2019s disease: Results from a 12-month prospective case series. Neuroscience Letters. 2016; 629: 165\u2013170.","DOI":"10.1016\/j.neulet.2016.07.006."},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Alves JN, Westner BU, H\u00f8jlund A, Weil RS, Dalal SS. Structural and functional changes in the retina in Parkinson\u2019s disease. Journal of Neurology, Neurosurgery, and Psychiatry. 2023; 94: 448\u2013456.","DOI":"10.1136\/jnnp-2022-329342."},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"London A, Benhar I, Schwartz M. The retina as a window to the brain-from eye research to CNS disorders. Nature Reviews. Neurology. 2013; 9: 44\u201353.","DOI":"10.1038\/nrneurol.2012.227."},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Srinivasan S, Efron N. Optical coherence tomography in the investigation of systemic neurologic disease. Clinical & Experimental Optometry. 2019; 102: 309\u2013319.","DOI":"10.1111\/cxo.12858."},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Kromer R, Serbecic N, Hausner L, Froelich L, Aboul-Enein F, Beutelspacher SC. Detection of Retinal Nerve Fiber Layer Defects in Alzheimer\u2019s Disease Using SD-OCT. Frontiers in Psychiatry. 2014; 5: 22.","DOI":"10.3389\/fpsyt.2014.00022."},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Lu Y, Li Z, Zhang X, Ming B, Jia J, Wang R, et al. Retinal nerve fiber layer structure abnormalities in early Alzheimer\u2019s disease: evidence in optical coherence tomography. Neuroscience Letters. 2010; 480: 69\u201372.","DOI":"10.1016\/j.neulet.2010.06.006."},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, Garc\u00eda-Layana A, Bejarano B, Villoslada P. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology. 2007; 68: 1488\u20131494.","DOI":"10.1212\/01.wnl.0000260612.51849.ed."},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Wong TY, Klein R, Sharrett AR, Nieto FJ, Boland LL, Couper DJ, et al. Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke. 2002; 33: 1487\u20131492.","DOI":"10.1161\/01.str.0000016789.56668.43."},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Kashani AH, Chen CL, Gahm JK, Zheng F, Richter GM, Rosenfeld PJ, et al. Optical coherence tomography angiography: A comprehensive review of current methods and clinical applications. Progress in Retinal and Eye Research. 2017; 60: 66\u2013100.","DOI":"10.1016\/j.preteyeres.2017.07.002."},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Mei X, Qiu C, Zhou Q, Chen Z, Chen Y, Xu Z, et al. Changes in retinal multilayer thickness and vascular network of patients with Alzheimer\u2019s disease. Biomedical Engineering Online. 2021; 20: 97.","DOI":"10.1186\/s12938-021-00931-2."},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. American Journal of Ophthalmology. 2008; 146: 496\u2013500.","DOI":"10.1016\/j.ajo.2008.05.032."},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Spaide RF, Fujimoto JG, Waheed NK, Sadda SR, Staurenghi G. Optical coherence tomography angiography. Progress in Retinal and Eye Research. 2018; 64: 1\u201355.","DOI":"10.1016\/j.preteyeres.2017.11.003."},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Di Pippo M, Fragiotta S, Di Staso F, Scuderi L, Abdolrahimzadeh S. The Role of Alpha-Synuclein Deposits in Parkinson\u2019s Disease: A Focus on the Human Retina. International Journal of Molecular Sciences. 2023; 24: 4391.","DOI":"10.3390\/ijms24054391."},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Cameron JR, Megaw RD, Tatham AJ, McGrory S, MacGillivray TJ, Doubal FN, et al. Lateral thinking - Interocular symmetry and asymmetry in neurovascular patterning, in health and disease. Progress in Retinal and Eye Research. 2017; 59: 131\u2013157.","DOI":"10.1016\/j.preteyeres.2017.04.003."},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Pless ML. The eye as a window to the brain. Annals of the Academy of Medicine, Singapore. 2023; 52: 60\u201361.","DOI":"10.47102\/annals-acadmedsg.202317."},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Wang F, Zhong W, Yang Q, Zhao W, Liu X, Rao B, et al. Distribution and synaptic organization of substance P-like immunoreactive neurons in the mouse retina. Brain Structure & Function. 2023; 228: 1703\u20131724.","DOI":"10.1007\/s00429-023-02688-x."},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Kao CC, Hsieh HM, Chang YC, Chu HC, Yang YH, Sheu SJ. Optical Coherence Tomography Assessment of Macular Thickness in Alzheimer\u2019s Dementia with Different Neuropsychological Severities. Journal of Personalized Medicine. 2023; 13: 1118.","DOI":"10.3390\/jpm13071118."},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Kim JI, Kang BH. Decreased retinal thickness in patients with Alzheimer\u2019s disease is correlated with disease severity. PLoS ONE. 2019; 14: e0224180.","DOI":"10.1371\/journal.pone.0224180."},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez-Puebla L, de Hoz R, Salobrar-Garc\u00eda E, Arias-V\u00e1zquez A, Gonz\u00e1lez-Jim\u00e9nez M, Ram\u00edrez AI, et al. Age-Related Retinal Layer Thickness Changes Measured by OCT in APPNL-F\/NL-F Mice: Implications for Alzheimer\u2019s Disease. International Journal of Molecular Sciences. 2024; 25: 8221.","DOI":"10.3390\/ijms25158221."},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Manchanda R, Samanta R, Narayan ML, Kumar M, Tiwari A, Agarwal A, et al. Connecting the Dots: Exploring the Relationship between Optical Coherence Tomography and 99mTc-TRODAT-1 SPECT Parameters in Parkinson\u2019s Disease. Annals of Indian Academy of Neurology. 2024; 27: 188\u2013195.","DOI":"10.4103\/aian.aian_31_24."},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"K\u0131l\u0131\u00e7 OHT, Bayram ZN, Kiyat P, Karti O, Aral A, Munis ND, et al. Examination of optical coherence tomography findings in patients with pregabalin use disorder. PeerJ. 2024; 12: e18395.","DOI":"10.7717\/peerj.18395."},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Allen A, Robbins CB, Joseph S, Hemesat A, Kundu A, Ma JP, et al. Angioarchitectural alterations in the retina and choroid in frontotemporal dementia. PLoS ONE. 2024; 19: e0312118.","DOI":"10.1371\/journal.pone.0312118."},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Chen CL, Zhang A, Bojikian KD, Wen JC, Zhang Q, Xin C, et al. Peripapillary Retinal Nerve Fiber Layer Vascular Microcirculation in Glaucoma Using Optical Coherence Tomography-Based Microangiography. Investigative Ophthalmology & Visual Science. 2016; 57: OCT475\u2013OCT485.","DOI":"10.1167\/iovs.15-18909."},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Hirasawa K, Yamaguchi J, Nagano K, Kanno J, Kasahara M, Shoji N. Degree of loss in the tissue thickness, microvascular density, specific perimetry and standard perimetry in early glaucoma. BMJ Open Ophthalmology. 2023; 8: e001256.","DOI":"10.1136\/bmjophth-2023-001256."},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"El-Kattan MM, Esmat SM, Esmail EH, Deraz HA, Ismail RS. Optical coherence tomography in patients with Parkinson\u2019s disease. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2022; 58: 21.","DOI":"10.1186\/s41983-021-00421-1."},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-de-Eguileta A, Cerver\u00f3 A, Ruiz de Sabando A, S\u00e1nchez-Juan P, Casado A. Ganglion Cell Layer Thinning in Alzheimer\u2019s Disease. Medicina. 2020; 56: 553.","DOI":"10.3390\/medicina56100553."},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-de-Eguileta A, Lage C, L\u00f3pez-Garc\u00eda S, Pozueta A, Garc\u00eda-Mart\u00ednez M, Kazimierczak M, et al. Ganglion cell layer thinning in prodromal Alzheimer\u2019s disease defined by amyloid PET. Alzheimer\u2019s & Dementia. 2019; 5: 570\u2013578.","DOI":"10.1016\/j.trci.2019.08.008."},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Chorostecki J, Seraji-Bozorgzad N, Shah A, Bao F, Bao G, George E, et al. Characterization of retinal architecture in Parkinson\u2019s disease. Journal of the Neurological Sciences. 2015; 355: 44\u201348.","DOI":"10.1016\/j.jns.2015.05.007."},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Pilat A, McLean RJ, Proudlock FA, Maconachie GDE, Sheth V, Rajabally YA, et al. In Vivo Morphology of the Optic Nerve and Retina in Patients With Parkinson\u2019s Disease. Investigative Ophthalmology & Visual Science. 2016; 57: 4420\u20134427.","DOI":"10.1167\/iovs.16-20020."},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Trost A, Lange S, Schroedl F, Bruckner D, Motloch KA, Bogner B, et al. Brain and Retinal Pericytes: Origin, Function and Role. Frontiers in Cellular Neuroscience. 2016; 10: 20.","DOI":"10.3389\/fncel.2016.00020."},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Abdolrahimzadeh S, Felli L, Plateroti AM, Perdicchi A, Contestabile MT, Recupero SM. Spectral Domain Optical Coherence Tomography Evidence of Retinal Nerve Fiber Layer and Ganglion Cell Loss in Adult Patients with Neurofibromatosis Type 1. Retina. 2016; 36: 75\u201381.","DOI":"10.1097\/IAE.0000000000000650."},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"L\u00f3pez-de-Eguileta A, L\u00f3pez-Garc\u00eda S, Lage C, Pozueta A, Garc\u00eda-Mart\u00ednez M, Kazimierczak M, et al. The retinal ganglion cell layer reflects neurodegenerative changes in cognitively unimpaired individuals. Alzheimer\u2019s Research & Therapy. 2022; 14: 57.","DOI":"10.1186\/s13195-022-00998-6."},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Blanks JC, Torigoe Y, Hinton DR, Blanks RH. Retinal pathology in Alzheimer\u2019s disease. I. Ganglion cell loss in foveal\/parafoveal retina. Neurobiology of Aging. 1996; 17: 377\u2013384.","DOI":"10.1016\/0197-4580(96)00010-3."},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Blanks JC, Hinton DR, Sadun AA, Miller CA. Retinal ganglion cell degeneration in Alzheimer\u2019s disease. Brain Research. 1989; 501: 364\u2013372.","DOI":"10.1016\/0006-8993(89)90653-7."},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Hart de Ruyter FJ, Morrema THJ, den Haan J, Netherlands Brain Bank, Twisk JWR, de Boer JF, et al. Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer\u2019s disease and primary tauopathies. Acta Neuropathologica. 2023; 145: 197\u2013218.","DOI":"10.1007\/s00401-022-02525-1."},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Davis MR, Robinson E, Koronyo Y, Salobrar-Garcia E, Rentsendorj A, Gaire BP, et al. Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer\u2019s disease. bioRxiv. 2024. (preprint)","DOI":"10.1101\/2024.09.17.613293."},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Yu DY, Cringle SJ, Balaratnasingam C, Morgan WH, Yu PK, Su EN. Retinal ganglion cells: Energetics, compartmentation, axonal transport, cytoskeletons and vulnerability. Progress in Retinal and Eye Research. 2013; 36: 217\u2013246.","DOI":"10.1016\/j.preteyeres.2013.07.001."},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Pini L, Pievani M, Bocchetta M, Altomare D, Bosco P, Cavedo E, et al. Brain atrophy in Alzheimer\u2019s Disease and aging. Ageing Research Reviews. 2016; 30: 25\u201348.","DOI":"10.1016\/j.arr.2016.01.002."},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Blennow K, de Leon MJ, Zetterberg H. Alzheimer\u2019s disease. Lancet. 2006; 368: 387\u2013403.","DOI":"10.1016\/S0140-6736(06)69113-7."},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Jack CR, Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia. 2018; 14: 535\u2013562.","DOI":"10.1016\/j.jalz.2018.02.018."},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Sabbagh MN, Lue LF, Fayard D, Shi J. Increasing Precision of Clinical Diagnosis of Alzheimer\u2019s Disease Using a Combined Algorithm Incorporating Clinical and Novel Biomarker Data. Neurology and Therapy. 2017; 6: 83\u201395.","DOI":"10.1007\/s40120-017-0069-5."},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Morinaga A, Ono K, Ikeda T, Ikeda Y, Shima K, Noguchi-Shinohara M, et al. A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer\u2019s disease in a memory clinic. Dementia and Geriatric Cognitive Disorders. 2010; 30: 285\u2013292.","DOI":"10.1159\/000320265."},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Salamone G, Di Lorenzo C, Mosti S, Lupo F, Cravello L, Palmer K, et al. Color discrimination performance in patients with Alzheimer\u2019s disease. Dementia and Geriatric Cognitive Disorders. 2009; 27: 501\u2013507.","DOI":"10.1159\/000218366."},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Cormack FK, Tovee M, Ballard C. Contrast sensitivity and visual acuity in patients with Alzheimer\u2019s disease. International Journal of Geriatric Psychiatry. 2000; 15: 614\u2013620. <614::aid-gps153>3.0.co;2-0.","DOI":"10.1002\/1099-1166(200007)15:7"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Kavcic V, Vaughn W, Duffy CJ. Distinct visual motion processing impairments in aging and Alzheimer\u2019s disease. Vision Research. 2011; 51: 386\u2013395.","DOI":"10.1016\/j.visres.2010.12.004."},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Gilmore GC, Wenk HE, Naylor LA, Koss E. Motion perception and Alzheimer\u2019s disease. Journal of Gerontology. 1994; 49: P52\u2013P57.","DOI":"10.1093\/geronj\/49.2.p52."},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Kirby E, Bandelow S, Hogervorst E. Visual impairment in Alzheimer\u2019s disease: a critical review. Journal of Alzheimer\u2019s Disease. 2010; 21: 15\u201334.","DOI":"10.3233\/JAD-2010-080785."},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Iseri PK, Altina\u015f O, Tokay T, Y\u00fcksel N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. Journal of Neuro-Ophthalmology. 2006; 26: 18\u201324.","DOI":"10.1097\/01.wno.0000204645.56873.26."},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Ito Y, Sasaki M, Takahashi H, Nozaki S, Matsuguma S, Motomura K, et al. Quantitative Assessment of the Retina Using OCT and Associations with Cognitive Function. Ophthalmology. 2020; 127: 107\u2013118.","DOI":"10.1016\/j.ophtha.2019.05.021."},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Garcia-Martin E, Larrosa JM, Polo V, Satue M, Marques ML, Alarcia R, et al. Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration. American Journal of Ophthalmology. 2014; 157: 470\u2013478.e2.","DOI":"10.1016\/j.ajo.2013.09.028."},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Wisely CE, Wang D, Henao R, Grewal DS, Thompson AC, Robbins CB, et al. Convolutional neural network to identify symptomatic Alzheimer\u2019s disease using multimodal retinal imaging. The British Journal of Ophthalmology. 2022; 106: 388\u2013395.","DOI":"10.1136\/bjophthalmol-2020-317659."},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Santangelo R, Huang SC, Bernasconi MP, Falautano M, Comi G, Magnani G, et al. Neuro-Retina Might Reflect Alzheimer\u2019s Disease Stage. Journal of Alzheimer\u2019s Disease. 2020; 77: 1455\u20131468.","DOI":"10.3233\/JAD-200043."},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Cipollini V, Abdolrahimzadeh S, Troili F, De Carolis A, Calafiore S, Scuderi L, et al. Neurocognitive Assessment and Retinal Thickness Alterations in Alzheimer Disease: Is There a Correlation? Journal of Neuro-Ophthalmology. 2020; 40: 370\u2013377.","DOI":"10.1097\/WNO.0000000000000831."},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Wang X, Jiao B, Liu H, Wang Y, Hao X, Zhu Y, et al. Machine learning based on Optical Coherence Tomography images as a diagnostic tool for Alzheimer\u2019s disease. CNS Neuroscience & Therapeutics. 2022; 28: 2206\u20132217.","DOI":"10.1111\/cns.13963."},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"S\u00e1ez ME, Garc\u00eda-S\u00e1nchez A, de Rojas I, Alarc\u00f3n-Mart\u00edn E, Mart\u00ednez J, Cano A, et al. Genome-wide association study and polygenic risk scores of retinal thickness across the cognitive continuum: data from the NORFACE cohort. Alzheimer\u2019s Research & Therapy. 2024; 16: 38.","DOI":"10.1186\/s13195-024-01398-8."},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Lees AJ, Hardy J, Revesz T. Parkinson\u2019s disease. Lancet. 2009; 373: 2055\u20132066.","DOI":"10.1016\/S0140-6736(09)60492-X."},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson\u2019s disease. The Lancet. Neurology. 2021; 20: 385\u2013397.","DOI":"10.1016\/S1474-4422(21)00030-2."},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Jankovic J. Parkinson\u2019s disease: clinical features and diagnosis. Journal of Neurology, Neurosurgery, and Psychiatry. 2008; 79: 368\u2013376.","DOI":"10.1136\/jnnp.2007.131045."},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Chaudhuri KR, Odin P, Antonini A, Martinez-Martin P. Parkinson\u2019s disease: the non-motor issues. Parkinsonism & Related Disorders. 2011; 17: 717\u2013723.","DOI":"10.1016\/j.parkreldis.2011.02.018."},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Jia F, Fellner A, Kumar KR. Monogenic Parkinson\u2019s Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing. Genes. 2022; 13: 471.","DOI":"10.3390\/genes13030471."},{"key":"ref62","unstructured":"Kouli A, Torsney KM, Kuan W-L. Parkinson\u2019s Disease: Etiology, Neuropathology, and Pathogenesis. In Stoker TB, Greenland JC (eds) Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects. Codon Publications: Brisbane (AU). 2018."},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Ortu\u00f1o-Lizar\u00e1n I, Beach TG, Serrano GE, Walker DG, Adler CH, Cuenca N. Phosphorylated \u03b1-synuclein in the retina is a biomarker of Parkinson\u2019s disease pathology severity. Movement Disorders. 2018; 33: 1315\u20131324.","DOI":"10.1002\/mds.27392."},{"key":"ref64","unstructured":"Harnois C, Di Paolo T. Decreased dopamine in the retinas of patients with Parkinson\u2019s disease. Investigative Ophthalmology & Visual Science. 1990; 31: 2473\u20132475."},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Veys L, Vandenabeele M, Ortu\u00f1o-Lizar\u00e1n I, Baekelandt V, Cuenca N, Moons L, et al. Retinal \u03b1-synuclein deposits in Parkinson\u2019s disease patients and animal models. Acta Neuropathologica. 2019; 137: 379\u2013395.","DOI":"10.1007\/s00401-018-01956-z."},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Eschbach J, Danzer KM. \u03b1-Synuclein in Parkinson\u2019s disease: pathogenic function and translation into animal models. Neuro-Degenerative Diseases. 2014; 14: 1\u201317.","DOI":"10.1159\/000354615."},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Gir\u00e1ldez-P\u00e9rez R, Antol\u00edn-Vallesp\u00edn M, Mu\u00f1oz M, S\u00e1nchez-Capelo A. Models of \u03b1-synuclein aggregation in Parkinson\u2019s disease. Acta Neuropathologica Communications. 2014; 2: 176.","DOI":"10.1186\/s40478-014-0176-9."},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Surguchov A, McMahan B, Masliah E, Surgucheva I. Synucleins in ocular tissues. Journal of Neuroscience Research. 2001; 65: 68\u201377.","DOI":"10.1002\/jnr.1129."},{"key":"ref69","unstructured":"Mart\u00ednez-Navarrete GC, Mart\u00edn-Nieto J, Esteve-Rudd J, Angulo A, Cuenca N. Alpha synuclein gene expression profile in the retina of vertebrates. Molecular Vision. 2007; 13: 949\u2013961."},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Leger F, Fernagut PO, Canron MH, L\u00e9oni S, Vital C, Tison F, et al. Protein aggregation in the aging retina. Journal of Neuropathology and Experimental Neurology. 2011; 70: 63\u201368.","DOI":"10.1097\/NEN.0b013e31820376cc."},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Archibald NK, Clarke MP, Mosimann UP, Burn DJ. The retina in Parkinson\u2019s disease. Brain. 2009; 132: 1128\u20131145.","DOI":"10.1093\/brain\/awp068."},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Beach TG, Carew J, Serrano G, Adler CH, Shill HA, Sue LI, et al. Phosphorylated \u03b1-synuclein-immunoreactive retinal neuronal elements in Parkinson\u2019s disease subjects. Neuroscience Letters. 2014; 571: 34\u201338.","DOI":"10.1016\/j.neulet.2014.04.027."},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"Peng X, Tehranian R, Dietrich P, Stefanis L, Perez RG. Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells. Journal of Cell Science. 2005; 118: 3523\u20133530.","DOI":"10.1242\/jcs.02481."},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Bodis-Wollner I, Kozlowski PB, Glazman S, Miri S. \u03b1-synuclein in the inner retina in parkinson disease. Annals of Neurology. 2014; 75: 964\u2013966.","DOI":"10.1002\/ana.24182."},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Huang L, Wang C, Wang W, Wang Y, Zhang R. The specific pattern of retinal nerve fiber layer thinning in Parkinson\u2019s disease: a systematic review and meta-analysis. Journal of Neurology. 2021; 268: 4023\u20134032.","DOI":"10.1007\/s00415-020-10094-0."},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Chang Z, Xie F, Li H, Yuan F, Zeng L, Shi L, et al. Retinal Nerve Fiber Layer Thickness and Associations With Cognitive Impairment in Parkinson\u2019s Disease. Frontiers in Aging Neuroscience. 2022; 14: 832768.","DOI":"10.3389\/fnagi.2022.832768."},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"Lee JY, Kim JM, Ahn J, Kim HJ, Jeon BS, Kim TW. Retinal nerve fiber layer thickness and visual hallucinations in Parkinson\u2019s Disease. Movement Disorders. 2014; 29: 61\u201367.","DOI":"10.1002\/mds.25543."},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Yang ZJ, Wei J, Mao CJ, Zhang JR, Chen J, Ji XY, et al. Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson\u2019s disease. Sleep & Breathing. 2016; 20: 1285\u20131292.","DOI":"10.1007\/s11325-016-1366-4."},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"Suciu VI, Suciu CI, Nicoar\u0103 SD, Perju-Dumbrav\u0103 L. Circumpapillary Retinal Nerve Fiber Layer OCT Imaging in a Parkinson\u2019s Disease Cohort-A Multidisciplinary Approach in a Clinical Research Hospital. Journal of Personalized Medicine. 2022; 12: 80.","DOI":"10.3390\/jpm12010080."},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A. Retinal nerve fiber layer thinning in Parkinson disease. Vision Research. 2004; 44: 2793\u20132797.","DOI":"10.1016\/j.visres.2004.06.009."},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Satue M, Obis J, Rodrigo MJ, Otin S, Fuertes MI, Vilades E, et al. Optical Coherence Tomography as a Biomarker for Diagnosis, Progression, and Prognosis of Neurodegenerative Diseases. Journal of Ophthalmology. 2016; 2016: 8503859.","DOI":"10.1155\/2016\/8503859."},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"Modestino EJ, Reinhofer A, Blum K, Amenechi C, O\u2019Toole P. Hoehn and Yahr staging of Parkinson\u2019s disease in relation to neuropsychological measures. Frontiers in Bioscience (Landmark Edition). 2018; 23: 1370\u20131379.","DOI":"10.2741\/4649."},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Bayhan HA, Aslan Bayhan S, Tan\u0131k N, G\u00fcrdal C. The association of spectral-domain optical coherence tomography determined ganglion cell complex parameters and disease severity in Parkinson\u2019s disease. Current Eye Research. 2014; 39: 1117\u20131122.","DOI":"10.3109\/02713683.2014.894080."},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"Murueta-Goyena A, Del Pino R, Gald\u00f3s M, Arana B, Acera M, Carmona-Abell\u00e1n M, et al. Retinal Thickness Predicts the Risk of Cognitive Decline in Parkinson Disease. Annals of Neurology. 2021; 89: 165\u2013176.","DOI":"10.1002\/ana.25944."},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"Sari ES, Koc R, Yazici A, Sahin G, Ermis SS. Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association with disease severity and duration. Journal of Neuro-Ophthalmology. 2015; 35: 117\u2013121.","DOI":"10.1097\/WNO.0000000000000203."},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"\u017divkovi\u0107 M, Dayanir V, Stamenovi\u0107 J, Ljubisavljevi\u0107 S, Pra\u017ei\u0107 A, Zlatanovi\u0107 M, et al. Retinal ganglion cell\/inner plexiform layer thickness in patients with Parkinson\u2019s disease. Folia Neuropathologica. 2017; 55: 168\u2013173.","DOI":"10.5114\/fn.2017.68584."},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Ahn J, Lee JY, Kim TW, Yoon EJ, Oh S, Kim YK, et al. Retinal thinning associates with nigral dopaminergic loss in de novo Parkinson disease. Neurology. 2018; 91: e1003\u2013e1012.","DOI":"10.1212\/WNL.0000000000006157."},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"Lee YW, Lim MN, Lee JY, Yoo YJ. Central retina thickness measured with spectral-domain optical coherence tomography in Parkinson disease: A meta-analysis. Medicine. 2023; 102: e35354.","DOI":"10.1097\/MD.0000000000035354."},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Mwanza JC, Oakley JD, Budenz DL, Chang RT, Knight OJ, Feuer WJ. Macular ganglion cell-inner plexiform layer: automated detection and thickness reproducibility with spectral domain-optical coherence tomography in glaucoma. Investigative Ophthalmology & Visual Science. 2011; 52: 8323\u20138329.","DOI":"10.1167\/iovs.11-7962."},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"Hajee ME, March WF, Lazzaro DR, Wolintz AH, Shrier EM, Glazman S, et al. Inner retinal layer thinning in Parkinson disease. Archives of Ophthalmology. 2009; 127: 737\u2013741.","DOI":"10.1001\/archophthalmol.2009.106."},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"Matlach J, Wagner M, Malzahn U, Schmidtmann I, Steigerwald F, Musacchio T, et al. Retinal changes in Parkinson\u2019s disease and glaucoma. Parkinsonism & Related Disorders. 2018; 56: 41\u201346.","DOI":"10.1016\/j.parkreldis.2018.06.016."},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"Kaur M, Saxena R, Singh D, Behari M, Sharma P, Menon V. Correlation Between Structural and Functional Retinal Changes in Parkinson Disease. Journal of Neuro-Ophthalmology. 2015; 35: 254\u2013258.","DOI":"10.1097\/WNO.0000000000000240."},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"Rascun\u00e0 C, Russo A, Terravecchia C, Castellino N, Avitabile T, Bonfiglio V, et al. Retinal Thickness and Microvascular Pattern in Early Parkinson\u2019s Disease. Frontiers in Neurology. 2020; 11: 533375.","DOI":"10.3389\/fneur.2020.533375."},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"Zhou WC, Tao JX, Li J. Optical coherence tomography measurements as potential imaging biomarkers for Parkinson\u2019s disease: A systematic review and meta-analysis. European Journal of Neurology. 2021; 28: 763\u2013774.","DOI":"10.1111\/ene.14613."},{"key":"ref95","unstructured":"Goldenberg MM. Multiple sclerosis review. P & T: a Peer-reviewed Journal for Formulary Management. 2012; 37: 175\u2013184."},{"key":"ref96","doi-asserted-by":"publisher","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet. Neurology. 2018; 17: 162\u2013173.","DOI":"10.1016\/S1474-4422(17)30470-2."},{"key":"ref97","unstructured":"Katz B. The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial. Transactions of the American Ophthalmological Society. 1995; 93: 685\u2013708."},{"key":"ref98","doi-asserted-by":"publisher","unstructured":"Castro SMC, Damasceno A, Damasceno BP, Vasconcellos JPD, Reis F, Iyeyasu JN, et al. Visual pathway abnormalities were found in most multiple sclerosis patients despite history of previous optic neuritis. Arquivos De Neuro-Psiquiatria. 2013; 71: 437\u2013441.","DOI":"10.1590\/0004-282X20130058."},{"key":"ref99","unstructured":"Shaygannejad V, Golabchi K, Dehghani A, Ashtari F, Haghighi S, Mirzendehdel M, et al. Color blindness among multiple sclerosis patients in Isfahan. Journal of Research in Medical Sciences. 2012; 17: 254\u2013257."},{"key":"ref100","doi-asserted-by":"publisher","unstructured":"Garrett B, Dmytriw AA, Maxner C. Acute optic neuritis in multiple sclerosis. CMAJ: Canadian Medical Association Journal. 2016; 188: E199.","DOI":"10.1503\/cmaj.150811."},{"key":"ref101","doi-asserted-by":"publisher","unstructured":"Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R. Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain. 2010; 133: 1591\u20131601.","DOI":"10.1093\/brain\/awq080."},{"key":"ref102","doi-asserted-by":"publisher","unstructured":"Syc SB, Saidha S, Newsome SD, Ratchford JN, Levy M, Ford E, et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain. 2012; 135: 521\u2013533.","DOI":"10.1093\/brain\/awr264."},{"key":"ref103","doi-asserted-by":"publisher","unstructured":"\u00d6zbilen KT, G\u00fcnd\u00fcz T, Kartal SN\u00c7, Ceylan NA, Eraksoy M, K\u00fcrt\u00fcnc\u00fc M. Detailed Evaluation of Macular Ganglion Cell Complex in Patients with Multiple Sclerosis. Noro Psikiyatri Arsivi. 2021; 58: 176\u2013183.","DOI":"10.29399\/npa.27531."},{"key":"ref104","doi-asserted-by":"publisher","unstructured":"Britze J, Pihl-Jensen G, Frederiksen JL. Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a systematic review and meta-analysis. Journal of Neurology. 2017; 264: 1837\u20131853.","DOI":"10.1007\/s00415-017-8531-y."},{"key":"ref105","doi-asserted-by":"publisher","unstructured":"Singh S, Dallenga T, Winkler A, Roemer S, Maruschak B, Siebert H, et al. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis. Journal of Neuroinflammation. 2017; 14: 57.","DOI":"10.1186\/s12974-017-0831-8."},{"key":"ref106","doi-asserted-by":"publisher","unstructured":"Saidha S, Syc SB, Durbin MK, Eckstein C, Oakley JD, Meyer SA, et al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Multiple Sclerosis. 2011; 17: 1449\u20131463.","DOI":"10.1177\/1352458511418630."},{"key":"ref107","doi-asserted-by":"publisher","unstructured":"Lee JY, Taghian K, Petratos S. Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability? Acta Neuropathologica Communications. 2014; 2: 97.","DOI":"10.1186\/s40478-014-0097-7."},{"key":"ref108","doi-asserted-by":"publisher","unstructured":"Meyer-Moock S, Feng YS, Maeurer M, Dippel FW, Kohlmann T. Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis. BMC Neurology. 2014; 14: 58.","DOI":"10.1186\/1471-2377-14-58."},{"key":"ref109","doi-asserted-by":"publisher","unstructured":"Querques G, Borrelli E, Sacconi R, De Vitis L, Leocani L, Santangelo R, et al. Functional and morphological changes of the retinal vessels in Alzheimer\u2019s disease and mild cognitive impairment. Scientific Reports. 2019; 9: 63.","DOI":"10.1038\/s41598-018-37271-6."},{"key":"ref110","doi-asserted-by":"publisher","unstructured":"Knier B, Leppenetier G, Wetzlmair C, Aly L, Hoshi MM, Pernpeintner V, et al. Association of Retinal Architecture, Intrathecal Immunity, and Clinical Course in Multiple Sclerosis. JAMA Neurology. 2017; 74: 847\u2013856.","DOI":"10.1001\/jamaneurol.2017.0377."},{"key":"ref111","doi-asserted-by":"publisher","unstructured":"Al-Hawasi A, Lagali N. Retinal ganglion cell layer thickness and volume measured by OCT changes with age, sex, and axial length in a healthy population. BMC Ophthalmology. 2022; 22: 278.","DOI":"10.1186\/s12886-022-02488-7."},{"key":"ref112","doi-asserted-by":"publisher","unstructured":"Liu Z, Saeedi O, Zhang F, Villanueva R, Asanad S, Agrawal A, et al. Quantification of Retinal Ganglion Cell Morphology in Human Glaucomatous Eyes. Investigative Ophthalmology & Visual Science. 2021; 62: 34.","DOI":"10.1167\/iovs.62.3.34."},{"key":"ref113","doi-asserted-by":"publisher","unstructured":"Soltanian-Zadeh S, Kurokawa K, Liu Z, Zhang F, Saeedi O, Hammer DX, et al. Weakly supervised individual ganglion cell segmentation from adaptive optics OCT images for glaucomatous damage assessment. Optica. 2021; 8: 642\u2013651.","DOI":"10.1364\/optica.418274."},{"key":"ref114","doi-asserted-by":"publisher","unstructured":"Sharma S, Chitranshi N, Wall RV, Basavarajappa D, Gupta V, Mirzaei M, et al. Trans-synaptic degeneration in the visual pathway: Neural connectivity, pathophysiology, and clinical implications in neurodegenerative disorders. Survey of Ophthalmology. 2022; 67: 411\u2013426.","DOI":"10.1016\/j.survophthal.2021.06.001."}],"container-title":["Journal of Integrative Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/JIN\/24\/5\/10.31083\/JIN26039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T12:23:54Z","timestamp":1749039834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/JIN\/24\/5\/10.31083\/JIN26039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":114,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"alternative-id":["S0219-6352(24)00888-X"],"URL":"https:\/\/doi.org\/10.31083\/jin26039","relation":{},"ISSN":["0219-6352","1757-448X"],"issn-type":[{"value":"0219-6352","type":"print"},{"value":"1757-448X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"article-number":"26039"}}